arginine and glucagon-like peptide 1

arginine has been researched along with glucagon-like peptide 1 in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (6.25)	18.7374
1990's	6 (12.50)	18.2507
2000's	12 (25.00)	29.6817
2010's	22 (45.83)	24.3611
2020's	5 (10.42)	2.80

Authors

Authors	Studies
Oshima, I; Shima, K; Yamamoto, C	1
Holst, JJ; Jeppesen, J; Madsbad, S; Orskov, C	1
Arnold, R; Fehmann, HC; Göke, B; Göke, R	1
Shima, K	1
Hirota, M; Nishino, T; Ohboshi, C; Shima, K; Shimizu, I	1
Baldissera, FG; Holst, JJ; Knuhtsen, S; Nielsen, OV; Orskov, C; Poulsen, SS	1
Hirota, M; Nishino, T; Ohboshi, C; Sato, M; Shima, K	1
Bloom, SR; Ghatei, MA; Owji, AA; Smith, DM; Wang, RM; Wang, Z	1
Yada, T; Yaekura, K; Yanagida, K	1
Fritsche, A; Hardt, E; Häring, H; Schützenauer, S; Stefan, N; Stumvoll, M	1
Fritsche, A; Hardt, E; Häring, H; Stefan, N; Stumvoll, M	2
Abdel-Halim, SM; Ahrén, B; Guenifi, A	1
Hellström, PM; Näslund, E; Tolessa, T	1
D'Alessio, DA; Greenbaum, CJ; Prigeon, RL	1
Buchan, AM; Ehses, J; Hinke, SA; Lynn, FC; McIntosh, CH; Miyawaki, K; Pamir, N; Pederson, RA; Pospisilik, JA; Seino, Y; Yamada, Y	1
Dou, H; Li, KS; Mao, JF; Yang, SS; Zhang, ZZ	1
Holst, JJ; Ikeda, H; Matsumura, K; Miki, T; Minami, K; Saraya, A; Seino, S; Shinozaki, H; Yamada, Y	1
't Hart, LM; Dekker, JM; Fritsche, A; Gallwitz, B; Häring, HU; Holst, JJ; Machicao, F; Nijpels, G; Schäfer, SA; Stefan, N; t'Hart, LM; Thamer, C; Tschritter, O; van Haeften, TW	1
Markmann, JF; Mueller, R; Naji, A; Rickels, MR	1
Fukuda, S; Ishii, Y; Matsui, K; Matsushita, M; Miyajima, K; Nishizawa, E; Oda, T; Ohta, T; Sano, R; Sasase, T; Ueda, N; Yamamoto, H	1
Asmar, M; Holst, JJ; Kielgast, U; Madsbad, S	1
Aoyama, T; Fujiwara, H; Fujiwara, T; Iwasa, M; Kawamura, I; Kobayashi, H; Minatoguchi, S; Nishigaki, K; Shiraki, T; Sumi, S; Takemura, G; Ushikoshi, H; Yamada, Y; Yamaki, T; Yasuda, S	1
Burkhardt, BR; Carnegie, JR; Cook, JR; Robert-Cooperman, CE; Wilson, CG; Wolf, BA; Wu, J; Yang, J; Young, RA	1
Naji, A; Rickels, MR	1
Flatt, PR; Kelly, C; McClenaghan, NH; McCluskey, JT; Parke, HG	1
Kim, SW; Kim, TI; Lee, M	1
Anders, S; Forst, T; Michelson, G; Mitry, M; Pfützner, A; Ratter, F; Weber, MM; Wilhelm, B	1
Kim, PH; Kim, SW; Lee, M	1
Gillespie, DG; Jackson, EK; Kochanek, SJ	1
Fukami, K; Ishibashi, Y; Maeda, S; Matsui, T; Nishino, Y; Ojima, A; Takeuchi, M; Yamagishi, S	1
Bräuner-Osborne, H; Clemmensen, C; D'Alessio, DA; Ryan, KK; Seeley, RJ; Smajilovic, S; Smith, EP; Woods, SC	1
Björklund, A; Islam, MS; Krishnan, K; Ma, Z	1
Ahrén, B; Omar, B; Sörhede-Winzell, M	1
Holst, JJ; Karstoft, K; Knudsen, SH; Pedersen, BK; Solomon, TP; Winding, K	1
Alamshah, A; Amin, A; Banks, K; Bloom, SR; Cheong, W; Cox, HM; France, R; Hyberg, G; Kinsey-Jones, JS; Lehmann, A; McGavigan, AK; Moolla, A; Murphy, KG; Norton, M; O'Hara, HC; Spreckley, E; Tough, IR	1
Al-Mrabeh, A; Aribasala, B; Batterham, RL; Hollingsworth, KG; Pucci, A; Small, PK; Steven, S; Taylor, R; Woodcock, SA	1
Bräuner-Osborne, H; Clemmensen, C; Jørgensen, CV; Smajilovic, S	1
Haczku, A; Kenyon, N; Linderholm, A; Nguyen, DV	1
't Hart, LM; Adamski, J; Beekman, M; Bernigau, W; Boeing, H; Boomsma, DI; Breier, M; Brunak, S; de Geus, EJC; Deelen, J; Draisma, HH; Eekhoff, EMW; Floegel, A; Gieger, C; Grallert, H; Gudmundsdottir, V; Gupta, R; Haid, M; Herder, C; Hummel, S; Jonsson, A; Kramer, MHH; McCarthy, MI; Molnos, S; Much, D; Pearson, ER; Pedersen, HK; Peters, A; Pischon, T; Pool, R; Prehn, C; Rathmann, W; Roden, M; Schulze, MB; Simonis-Bik, AMC; Slagboom, PE; Suhre, K; Thorand, B; van Heemst, D; van Leeuwen, N; Wahl, S; Wang-Sattler, R; Willemsen, G; Ziegler, AG	1
Calle, RA; Cobelli, C; Fryburg, DA; Gebauer, M; Ghosh, A; Raymond, RH; Robertson, RP; Ruetten, H; Shankar, SS; Staten, MA; Stefanovski, D; Vella, A; Wright, K	1
Alamshah, A; Amin, A; Bloom, SR; Martin, NM; Murphy, KG; Neophytou, C; Spreckley, E; Thein, S	1
Bazile, D; Beirne, J; Bhattacharjee, S; Brayden, DJ; Hristov, D; Mahon, E; McCartney, F; Penarier, G; Reid, S; Werner, U	1
D'Alessio, DA; Gray, SM; Hoselton, AL; Krishna, R; Slentz, CA	1
D'Alessio, DA; De Leon, DD; Doliba, A; Eiel, JN; Flatt, AJ; Gallagher, K; Gallop, R; Hadjiliadis, D; Kelly, A; Nyirjesy, SC; Peleckis, AJ; Rickels, MR; Rubenstein, RC; Sheikh, S; Stefanovski, D; Tami, A	1
Binou, P; Halabalaki, M; Karathanos, VT; Kokkinos, A; Konstantopoulos, P; Papaioannou, V; Simati, S; Yanni, AE	1
Bełtowski, J; Czechowska, G; Fornal, E; Góralczyk, A; Korolczuk, A; Kozub, A; Marzec-Kotarska, B; Nikolaichuk, H; Pradiuch, A; Stachniuk, A; Trzpil, A; Wójcicka, G	1

Reviews

1 review(s) available for arginine and glucagon-like peptide 1

Article	Year
Glucagon-like peptide 1: A potential anti-inflammatory pathway in obesity-related asthma. Pharmacology & therapeutics, 2017, Volume: 180 Topics: Animals; Arginine; Asthma; Glucagon-Like Peptide 1; Glycation End Products, Advanced; Humans; Inflammation; Lung; Obesity; Receptor for Advanced Glycation End Products	2017

Trials

7 trial(s) available for arginine and glucagon-like peptide 1

Article	Year
A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility. European journal of clinical investigation, 2000, Volume: 30, Issue:5 Topics: Adult; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Protein Precursors; Reproducibility of Results	2000
Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. Diabetes, 2002, Volume: 51, Issue:4 Topics: Arginine; Autoantibodies; Blood Glucose; Diabetes Mellitus, Type 1; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Peptide Fragments; Reference Values	2002
Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function. Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:9 Topics: Adult; Aged; Arginine; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; E-Selectin; Endothelium, Vascular; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Liraglutide; Male; Metformin; Microcirculation; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Prospective Studies	2012
Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span. Diabetes care, 2014, Volume: 37, Issue:3 Topics: Adolescent; Adult; Aged; Arginine; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gastroplasty; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Liraglutide; Male; Metformin; Middle Aged; Prediabetic State; Young Adult	2014
Calorie restriction and not glucagon-like peptide-1 explains the acute improvement in glucose control after gastric bypass in Type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association, 2016, Volume: 33, Issue:12 Topics: Adipose Tissue; Adult; Aged; Amino Acids; Arginine; Blood Glucose; Body Composition; Caloric Restriction; Chromium; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Glucagon-Like Peptide 1; Glucose; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipase; Liver; Male; Membrane Proteins; Middle Aged; Nicotinic Acids; Pancreas; Triglycerides	2016
Effects of GLP-1 and GIP on Islet Function in Glucose-Intolerant, Pancreatic-Insufficient Cystic Fibrosis. Diabetes, 2022, 10-01, Volume: 71, Issue:10 Topics: Adult; Arginine; Blood Glucose; Cystic Fibrosis; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Proinsulin	2022
Postprandial Glucose and Gastrointestinal Hormone Responses of Healthy Subjects to Wheat Biscuits Enriched with L-Arginine or Branched-Chain Amino Acids of Plant Origin. Nutrients, 2022, Oct-19, Volume: 14, Issue:20 Topics: Amino Acids, Branched-Chain; Arginine; Blood Glucose; Cross-Over Studies; Gastrointestinal Hormones; Ghrelin; Glicentin; Glucagon-Like Peptide 1; Glucose; Healthy Volunteers; Humans; Insulin; Isoleucine; Leucine; Peptide YY; Postprandial Period; Triticum; Valine	2022

Other Studies

40 other study(ies) available for arginine and glucagon-like peptide 1

Article	Year
Half-disappearance time of endogenous GLP-1 immunoreactivity in man. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1991, Volume: 23, Issue:5 Topics: Adult; Arginine; Chromatography, Gel; Glucagon; Glucagon-Like Peptide 1; Glucose; Half-Life; Humans; Peptide Fragments; Protein Precursors	1991
Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. The Journal of clinical investigation, 1991, Volume: 87, Issue:2 Topics: Administration, Oral; Adult; Aged; Arginine; Chromatography, Gel; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Infusions, Intravenous; Male; Middle Aged; Peptide Fragments; Proglucagon; Protein Precursors; Radioimmunoassay	1991
Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreas. Zeitschrift fur Gastroenterologie, 1990, Volume: 28, Issue:7 Topics: Animals; Arginine; Blood Glucose; Carbachol; Dose-Response Relationship, Drug; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Insulin; Male; Pancreas; Peptide Fragments; Peptides; Perfusion; Rats; Stimulation, Chemical	1990
[Digestive tract hormones and pancreatic secretion]. Nihon Naibunpi Gakkai zasshi, 1990, Dec-20, Volume: 66, Issue:12 Topics: Animals; Arginine; Blood Glucose; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Secretion; Intestines; Mice; Pancreatic Hormones; Peptide Fragments; Peptides; Protein Precursors; Rats; Sincalide	1990
A large molecular form of glucagon-like peptide-1 (GLP-1) immunoreactivity is co-released with glucagon from pancreas by arginine in normal subjects. Clinica chimica acta; international journal of clinical chemistry, 1987, Aug-31, Volume: 167, Issue:3 Topics: Adult; Arginine; Blood Glucose; Chromatography, Gel; Chromatography, High Pressure Liquid; Glucagon; Glucagon-Like Peptide 1; Humans; Injections, Intravenous; Insulin; Pancreas; Peptides	1987
Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology, 1986, Volume: 119, Issue:4 Topics: Animals; Arginine; Gastrin-Releasing Peptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose; Histocytochemistry; Immunoenzyme Techniques; Intestine, Small; Pancreas; Peptides; Proglucagon; Protein Precursors; Swine	1986
Release of glucagon-like peptide 1 immunoreactivity from the perfused rat pancreas. Acta endocrinologica, 1987, Volume: 114, Issue:4 Topics: Animals; Arginine; Chromatography, Gel; Chromatography, High Pressure Liquid; Glucagon; Glucagon-Like Peptide 1; Male; Pancreas; Peptides; Perfusion; Radioimmunoassay; Rats; Rats, Inbred Strains	1987
Glucagon-like peptide-1 is a physiological incretin in rat. The Journal of clinical investigation, 1995, Volume: 95, Issue:1 Topics: Anesthesia; Animals; Arginine; Cells, Cultured; Consciousness; Eating; Fasting; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glucose; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Pancreas; Peptide Fragments; Peptides; Protein Precursors; Radioligand Assay; Rats; Rats, Wistar; Receptors, Glucagon; Vasoactive Intestinal Peptide	1995
PACAP and GLP-1 protect islet beta-cells against Ca2+ toxicity induced by high K+. Annals of the New York Academy of Sciences, 1998, Dec-11, Volume: 865 Topics: Animals; Arginine; Calcium; Cells, Cultured; Glucagon; Glucagon-Like Peptide 1; Glucose; Islets of Langerhans; Neuropeptides; Nifedipine; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Potassium Chloride; Protein Precursors; Rats; Rats, Wistar; Tolbutamide	1998
Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion. Diabetologia, 2000, Volume: 43, Issue:7 Topics: Adult; Arginine; Blood Glucose; C-Peptide; Fasting; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Glucose Intolerance; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Peptide Fragments; Reference Values	2000
Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro. Pancreas, 2001, Volume: 22, Issue:1 Topics: Animals; Arginine; Cholecystokinin; Drug Combinations; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Insulin; Insulin Secretion; Male; Mice; Pancreas; Peptide Fragments; Perfusion; Rats; Somatostatin	2001
The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the L-arginine/nitric oxide pathway. Regulatory peptides, 2001, Apr-02, Volume: 98, Issue:1-2 Topics: Animals; Arginine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fasting; Gastrointestinal Motility; Glucagon; Glucagon-Like Peptide 1; Male; Myoelectric Complex, Migrating; Nitric Oxide; Nitroarginine; Peptide Fragments; Protein Precursors; Rats; Rats, Sprague-Dawley	2001
Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction. The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:3 Topics: Adult; Arginine; Blood Glucose; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Middle Aged; Peptide Fragments; Proinsulin; Protein Precursors	2001
Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis. American journal of physiology. Endocrinology and metabolism, 2003, Volume: 284, Issue:5 Topics: Adaptation, Physiological; Animals; Arginine; Cyclic AMP; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Immunohistochemistry; In Vitro Techniques; Insulin; Intestines; Intracellular Membranes; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Knockout; Pancreas; Peptide Fragments; Protein Precursors; Receptors, Gastrointestinal Hormone; RNA, Messenger	2003
Expression, purification, and C-terminal amidation of recombinant human glucagon-like peptide-1. Protein expression and purification, 2004, Volume: 36, Issue:2 Topics: Animals; Arginine; Cathepsin A; Chromatography, Affinity; Chromatography, Ion Exchange; Cyanogen Bromide; Diabetes Mellitus, Type 2; Escherichia coli; Female; Gene Expression; Glucagon; Glucagon-Like Peptide 1; Glucose; Glutathione Transferase; Humans; Insulin; Leucine; Peptide Fragments; Protein Precursors; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins	2004
Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes, 2005, Volume: 54, Issue:4 Topics: Animals; Arginine; Blood Glucose; Food; Gastric Inhibitory Polypeptide; Gastrointestinal Motility; Glucagon; Glucagon-Like Peptide 1; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Knockout; Pancreas; Peptide Fragments; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Precursors; Time Factors	2005
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia, 2007, Volume: 50, Issue:12 Topics: Adult; Arginine; Blood Glucose; Female; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Heterozygote; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Polymorphism, Single Nucleotide; TCF Transcription Factors; Transcription Factor 7-Like 2 Protein	2007
Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:1 Topics: Adult; Arginine; Blood Glucose; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Humans; Insulin; Insulin-Secreting Cells; Islets of Langerhans Transplantation; Male; Middle Aged; Pancreas Transplantation; Proinsulin	2009
Pancreatic function of spontaneously diabetic torii rats in pre-diabetic stage. Experimental animals, 2009, Volume: 58, Issue:4 Topics: Animals; Arginine; Benzoates; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Obesity; Organ Culture Techniques; Pancreas; Peptide Fragments; Rats; Rats, Sprague-Dawley; Tolbutamide	2009
Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:5 Topics: Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Humans; Hyperglycemia; Insulin-Secreting Cells; Serum Albumin	2010
Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits. Journal of cardiovascular pharmacology, 2010, Volume: 55, Issue:6 Topics: alpha-Glucosidases; Animals; Arginine; Decanoic Acids; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Heart; Hydroxy Acids; Hypoglycemic Agents; Inositol; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphotransferases; Proto-Oncogene Proteins c-akt; Rabbits; Receptors, Glucagon; Reperfusion Injury	2010
Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function. Diabetes, 2010, Volume: 59, Issue:9 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arginine; Blood Glucose; Cytokines; DNA Primers; Gene Amplification; Glucagon-Like Peptide 1; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Knockout; Phenotype; Reference Values; Reverse Transcriptase Polymerase Chain Reaction	2010
Reactive hypoglycaemia following GLP-1 infusion in pancreas transplant recipients. Diabetes, obesity & metabolism, 2010, Volume: 12, Issue:8 Topics: Adult; Arginine; Diabetes Mellitus, Type 1; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Insulin-Secreting Cells; Male; Pancreas Transplantation	2010
The role of glucagon- and somatostatin-secreting cells in the regulation of insulin release and beta-cell function in heterotypic pseudoislets. Diabetes/metabolism research and reviews, 2010, Volume: 26, Issue:7 Topics: Alanine; Animals; Arginine; Cadherins; Cell Communication; Cell Proliferation; Cell Survival; Cells, Cultured; Connexin 43; Connexins; Gap Junction delta-2 Protein; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Somatostatin; Somatostatin-Secreting Cells	2010
Efficient GLP-1 gene delivery using two-step transcription amplification plasmid system with a secretion signal peptide and arginine-grafted bioreducible polymer. Journal of controlled release : official journal of the Controlled Release Society, 2012, Jan-30, Volume: 157, Issue:2 Topics: Animals; Arginine; Cell Line, Tumor; Genetic Therapy; Glucagon-Like Peptide 1; Insulin; Insulin Secretion; Mice; NIH 3T3 Cells; Plasmids; Polyamines; Protein Sorting Signals; Transcription, Genetic; Transfection	2012
Delivery of two-step transcription amplification exendin-4 plasmid system with arginine-grafted bioreducible polymer in type 2 diabetes animal model. Journal of controlled release : official journal of the Controlled Release Society, 2012, Aug-20, Volume: 162, Issue:1 Topics: Animals; Arginine; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; DNA; Drug Carriers; Exenatide; Gene Expression; Genetic Therapy; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Peptides; Plasmids; Polymers; Transcription, Genetic; Venoms	2012
Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:3 Topics: Animals; Arginine; Cell Proliferation; Cells, Cultured; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Glomerular Mesangium; Glucagon-Like Peptide 1; Male; Models, Animal; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptide YY; Proline; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sitagliptin Phosphate; Thymidine; Triazoles	2012
Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. The American journal of pathology, 2013, Volume: 182, Issue:1 Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Exenatide; Gene Expression Regulation, Enzymologic; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycation End Products, Advanced; Humans; Hypertrophy; Hypoglycemic Agents; Kidney; Kidney Glomerulus; Kidney Tubules; Macrophages; Male; Peptides; Protein-Arginine N-Methyltransferases; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Glucagon; Receptors, Immunologic; Repressor Proteins; RNA, Messenger; Venoms	2013
Oral L-arginine stimulates GLP-1 secretion to improve glucose tolerance in male mice. Endocrinology, 2013, Volume: 154, Issue:11 Topics: Animals; Arginine; Dietary Fats; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Intolerance; Glucose Tolerance Test; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Receptors, Glucagon	2013
Role of transient receptor potential melastatin-like subtype 5 channel in insulin secretion from rat β-cells. Pancreas, 2014, Volume: 43, Issue:4 Topics: Animals; Arginine; Calcium; Cells, Cultured; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Membrane Potentials; Organophosphorus Compounds; Rats, Sprague-Dawley; Signal Transduction; Time Factors; TRPM Cation Channels	2014
Conditional glucagon receptor overexpression has multi-faceted consequences for beta-cell function. Metabolism: clinical and experimental, 2014, Volume: 63, Issue:12 Topics: Animals; Arginine; Body Weight; Carbachol; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Mice; Mice, Transgenic; Receptors, Glucagon; Receptors, Muscarinic	2014
Effects of acute exercise on pancreatic endocrine function in subjects with type 2 diabetes. Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:2 Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Exercise; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Hyperglycemia; Infusions, Intravenous; Injections; Insulin; Insulin Secretion; Male; Pancreas; Treatment Outcome	2015
L-arginine promotes gut hormone release and reduces food intake in rodents. Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:5 Topics: Animals; Appetite Depressants; Arginine; Cells, Cultured; Dietary Supplements; Energy Intake; Energy Metabolism; Gastrointestinal Agents; Glucagon-Like Peptide 1; In Vitro Techniques; Injections, Intraperitoneal; Injections, Intraventricular; Intestinal Mucosa; Male; Mice, Inbred C57BL; Mice, Knockout; Obesity; Peptide YY; Random Allocation; Rats, Wistar; Receptors, G-Protein-Coupled; Weight Loss	2016
Robust GLP-1 secretion by basic L-amino acids does not require the GPRC6A receptor. Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:4 Topics: Amino Acids, Basic; Animals; Arginine; Glucagon-Like Peptide 1; Ligands; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Ornithine; Receptors, G-Protein-Coupled	2017
Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study. Diabetologia, 2018, Volume: 61, Issue:1 Topics: Arginine; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Insulin; Male; Risk Factors	2018
Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function. Metabolic syndrome and related disorders, 2018, Volume: 16, Issue:8 Topics: Administration, Intravenous; Arginine; Biomarkers; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Eating; Enteroendocrine Cells; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin-Secreting Cells; Peptide YY; Postprandial Period; Prediabetic State; Time Factors; United States	2018
L-Arginine Increases Postprandial Circulating GLP-1 and PYY Levels in Humans. Obesity (Silver Spring, Md.), 2018, Volume: 26, Issue:11 Topics: Adult; Appetite Depressants; Arginine; Double-Blind Method; Eating; Female; Glucagon-Like Peptide 1; Humans; Male; Peptide YY; Postprandial Period	2018
Silica-Coated Nanoparticles with a Core of Zinc, l-Arginine, and a Peptide Designed for Oral Delivery. ACS applied materials & interfaces, 2020, Jan-08, Volume: 12, Issue:1 Topics: Administration, Oral; Animals; Arginine; Chromatography, High Pressure Liquid; Circular Dichroism; Female; Glucagon-Like Peptide 1; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Nanoparticles; Peptides; Silicon Dioxide; Zinc	2020
GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1. The Journal of clinical endocrinology and metabolism, 2022, 08-18, Volume: 107, Issue:9 Topics: Arginine; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fasting; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Insulin; Insulin Secretion; Sitagliptin Phosphate	2022
The effect of exenatide (a GLP-1 analogue) and sitagliptin (a DPP-4 inhibitor) on asymmetric dimethylarginine (ADMA) metabolism and selected biomarkers of cardiac fibrosis in rats with fructose-induced metabolic syndrome. Biochemical pharmacology, 2023, Volume: 214 Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Chromatography, Liquid; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Fibrosis; Fructose; Glucagon-Like Peptide 1; Hypoglycemic Agents; Metabolic Syndrome; Nitric Oxide; Protease Inhibitors; Rats; Sitagliptin Phosphate; Tandem Mass Spectrometry	2023